Abortion Pill Politics
A federal court’s decision to restrict availability of the abortion pill mifepristone has launched abortion back into the national spotlight. It’s also raised new questions about the job security of FDA Commissioner Marty Makary. Sandhya Raman of Bloomberg Law, Shefali Luthra of The 19th, and Jessie Hellmann of CQ Roll Call join Ńîąóĺú´«Ă˝Ň•îl Health News’ Julie Rovner to discuss these stories and more. Also, Rovner interviews Ńîąóĺú´«Ă˝Ň•îl Health News’ Andrew Jones, who wrote the latest “Bill of the Month.”